152 related articles for article (PubMed ID: 30663807)
1. Bilateral radiation therapy followed by methotrexate-based chemotherapy for primary vitreoretinal lymphoma.
de la Fuente MI; Alderuccio JP; Reis IM; Omuro A; Markoe A; Echegaray JJ; Davis JL; Harbour JW; Lossos IS
Am J Hematol; 2019 Apr; 94(4):455-460. PubMed ID: 30663807
[TBL] [Abstract][Full Text] [Related]
2. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
[TBL] [Abstract][Full Text] [Related]
4. Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma.
Cheah CY; Milgrom S; Chihara D; Gombos DS; Pinnix CC; Dabaja BS; Fowler NH
Neuro Oncol; 2016 Apr; 18(4):575-81. PubMed ID: 26487691
[TBL] [Abstract][Full Text] [Related]
5. Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma.
Kaburaki T; Taoka K; Matsuda J; Yamashita H; Matsuda I; Tsuji H; Tanaka R; Nakazaki K; Nakamura F; Kamiya K; Kurokawa M; Ohtomo K; Aihara M
Br J Haematol; 2017 Oct; 179(2):246-255. PubMed ID: 28699673
[TBL] [Abstract][Full Text] [Related]
6. Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.
Lam M; Touitou V; Choquet S; Cassoux N; Ghesquières H; Kodjikian L; Schmitt A; Gattoussi S; Tabouret É; Sampo M; Blonski M; Angioi-Duprez K; Houot R; Mouriaux F; Gyan E; Le Lez ML; Moles MP; Croisé F; Chauchet A; Schwartz C; Ahle G; Meyer L; Gressin R; Chiquet C; Oberic L; Ollé P; Marolleau JP; Jany B; Tempescul A; Cochener B; Damaj G; Quintyn JC; Moluçon-Chabrot C; Rousseau E; Franciane P; Schneider C; Massé H; Tamburini-Bonnefoy J; Brézin A; Fornecker LM; Ballonzoli L; Le Garff-Tavernier M; Hoang-Xuan K; Bodaghi B; Soussain C; Houillier C
Am J Hematol; 2021 Jul; 96(7):823-833. PubMed ID: 33864703
[TBL] [Abstract][Full Text] [Related]
7. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
Hashida N; Nakai K; Saitoh N; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostics and treatment of primary vitreoretinal lymphoma].
Stübiger N; Kakkassery V; Gundlach E; Winterhalter S; Pleyer U
Ophthalmologe; 2015 Mar; 112(3):223-30. PubMed ID: 25698590
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.
Cheng CL; Yeh PT; Fang WQ; Ma WL; Hou HA; Tsai CH; Lin CP; Tien HF
Cancer Med; 2023 Apr; 12(7):8102-8111. PubMed ID: 36602288
[TBL] [Abstract][Full Text] [Related]
12. Recurrent pseudohypopyon in association with primary vitreoretinal lymphoma: a case report.
Kitao M; Hashida N; Nishida K
BMC Ophthalmol; 2016 Jul; 16():103. PubMed ID: 27391815
[TBL] [Abstract][Full Text] [Related]
13. How we diagnose and treat vitreoretinal lymphoma.
Fend F; Ferreri AJ; Coupland SE
Br J Haematol; 2016 Jun; 173(5):680-92. PubMed ID: 27133587
[TBL] [Abstract][Full Text] [Related]
14. Survival Outcomes of Primary Intraocular Lymphoma: A Single-institution Experience.
Kim MM; Dabaja BS; Medeiros J; Kim S; Allen P; Chevez-Barrios P; Gombos DS; Fowler N
Am J Clin Oncol; 2016 Apr; 39(2):109-13. PubMed ID: 24390272
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma.
Anthony CL; Bavinger JC; Shantha JG; O'Keefe GD; Pearce WA; Voloschin A; Grossniklaus HE; Yeh S
Int J Retina Vitreous; 2021 Dec; 7(1):72. PubMed ID: 34863313
[TBL] [Abstract][Full Text] [Related]
16. Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone.
Teckie S; Yahalom J
Leuk Lymphoma; 2014 Apr; 55(4):795-801. PubMed ID: 23822539
[TBL] [Abstract][Full Text] [Related]
17. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
18. An unusual case report of primary vitreoretinal lymphoma.
Tan SZ; Steeples LR; Chhabra R; Jones NP
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
[TBL] [Abstract][Full Text] [Related]
19. Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence.
Park YG; Park WK; Kim RY; Kim M; Park YH
Sci Rep; 2020 Oct; 10(1):15992. PubMed ID: 33009434
[TBL] [Abstract][Full Text] [Related]
20. Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.
DeAngelis LM; Yahalom J; Heinemann MH; Cirrincione C; Thaler HT; Krol G
Neurology; 1990 Jan; 40(1):80-6. PubMed ID: 2296388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]